With an appreciation for the role of hepatocyte-specific AMPK and an understanding of the beneficial effects of activating AMPK in the liver niche, the contribution of the immune compartment in the onset and progression of NASH remains unclear. The gene discussed is PRKAA2; the disease is metabolic dysfunction-associated steatohepatitis.